Wacker strengthens its pharmaceutical-protein business and buys Dutch biotech plant
Wacker Chemie AG has acquired a Dutch site to manufacture biopharmaceuticals, live microbial products and vaccines, plus the associated business, from SynCo Bio Luxembourg Sàrl
More From BioPortfolio on "Wacker strengthens its pharmaceutical-protein business and buys Dutch biotech plant"